Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.


Trump says historic summit with Xi, Putin already a 'win' before event
Saudi coalition reports damage after Houthi missile threat towards Riyadh
More than 47,000 evacuated in India ahead of Cyclone Akvan
Israel launches ground operation in central Gaza
Xi, Putin blast Western 'protectionism', sanctions as Trump lands in China